Patients were randomised into three induction therapy strategies : ( A ) combination therapy ( methotrexate ( MTX ) + sulfasalazine + hydroxychloroquine ) with GCs intramuscularly ; ( B ) combination therapy with an oral GC tapering scheme and ( C ) MTX with oral GCs similar to B.
